Phase 2 Lung Cancer Trial, Not Yet Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You must be 18 years old or older and willing to sign a consent form agreeing to take part.
- You should be generally well enough to carry out light activity or daily tasks (not severely limited by illness).
- You must have been diagnosed with advanced lung cancer (stage IIIB or IV, non-small cell type) that has continued to grow or spread after treatment with a type of immunotherapy called a PD-1 inhibitor.
- Doctors must expect you to live for at least 3 months, and you must have at least one area of cancer that can be measured on a scan.
- Your blood counts, liver, kidney, and blood clotting test results must meet certain levels set by the trial (confirm specific values with trial site).
- If you have had cancer spread to the brain, it must have been treated and be considered stable.
- If you could become pregnant, or if your partner could become pregnant, you must agree to use contraception during the trial.
Who may not be able to join:
- You have previously received certain other types of immunotherapy or specific cancer treatments (confirm which treatments apply with the trial site).
- You have certain types of cancer, specific gene mutations, or have recently taken steroid medications or drugs that suppress the immune system.
- You have brain or spinal fluid cancer spread that has not been treated or is not yet stable, a recent serious infection, or have had major surgery recently.
- You have other health conditions that could interfere with the trial, such as uncontrolled fluid build-up in body cavities, active autoimmune disease, significant bleeding or blood clotting problems, serious heart conditions, severe allergies to the trial drugs, another active cancer, HIV/AIDS, hepatitis B or C, or are currently taking part in another clinical trial (confirm timeframes with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Primary endpoints
Progression-free survival time (PFS)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.